SCHEMBL5574902

SCHEMBL5574902

CCCN1CC[C@@H](c2ccc(NS(=O)(=O)c3ccc(C(C)CC)cc3)cc2)C1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.45
LMNA P02545 2/20 0.45
MAPT P10636 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
TP53 P04637 1/20 0.45
ATM Q13315 1/20 0.45
DRD2 P14416 7/20 0.44
DRD3 P35462 5/20 0.44
KCNH2 Q12809 2/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
DRD1 P21728 2/20 0.41
DRD4 P21917 2/20 0.41
DRD5 P21918 2/20 0.41
CCR5 P51681 1/20 0.41
TRIM24 O15164 1/20 0.41
SLC2A1 P11166 1/20 0.40
SIGMAR1 Q99720 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5574905 1.00 ALDH1A1 (0.45) ALDH1A1LMNAMAPTSMN1; SMN2TP53
Hydrochloric Acid SCHEMBL1546986 0.99 ALDH1A1 (0.44) ALDH1A1LMNAMAPTSMN1; SMN2TP53
Hydrochloric Acid SCHEMBL1546989 0.99 ALDH1A1 (0.44) ALDH1A1LMNAMAPTSMN1; SMN2TP53
SCHEMBL1545864 0.93 DRD2 (0.52) ALDH1A1LMNAMAPTSMN1; SMN2TP53
SCHEMBL1545866 0.93 DRD2 (0.52) ALDH1A1LMNAMAPTSMN1; SMN2TP53
SCHEMBL5574178 0.93 DRD2 (0.52) ALDH1A1LMNAMAPTSMN1; SMN2TP53
SCHEMBL1562657 0.92 ALDH1A1 (0.43) ALDH1A1LMNAMAPTSMN1; SMN2TP53
SCHEMBL1546782 0.92 ALDH1A1 (0.43) ALDH1A1LMNAMAPTSMN1; SMN2TP53
SCHEMBL1563862 0.92 ALDH1A1 (0.43) ALDH1A1LMNAMAPTSMN1; SMN2TP53
SCHEMBL1546905 0.92 ALDH1A1 (0.43) ALDH1A1LMNAMAPTSMN1; SMN2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1814849-A1 HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR Abbott GmbH & Co. KG (DE) 2007-08-08 EP disclosed
WO-2006040182-A1 HETEROCYCLIC COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO MODULATION OF THE DOPAMINE D3 RECEPTOR ABBOTT GMBH & CO. KG (DE) 2006-04-20 WO disclosed